Join to View Full Profile
1021 Morehead Medical DrSte ACharlotte, NC 28204
Phone+1 980-442-2000
Fax+1 704-355-5800
Dr. Avalos is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
UCLA David Geffen School of Medicine/UCLA Medical CenterFellowship, Hematology and Medical Oncology, 1985 - 1986
Ohio State University HospitalFellowship, Hematology and Medical Oncology, 1984 - 1985- Ohio State University HospitalResidency, Internal Medicine, 1980 - 1983
- Ohio State University College of MedicineClass of 1980
Certifications & Licensure
NC State Medical License 2012 - 2025
OH State Medical License 1981 - 2025
American Board of Internal Medicine Internal Medicine- American Board of Internal Medicine Hematology
- American Board of Internal Medicine Medical Oncology
Clinical Trials
- LCI-HEM-SPEC-001: Tissue Collection for Genetic Analysis of Acute Myelogenous Leukemia Start of enrollment: 2013 Nov 01
- Factors Affecting Post-transplant Cyclophosphamide (PTCy) Efficacy Start of enrollment: 2018 Jul 13
Publications & Presentations
PubMed
- Venous Thromboembolism Incidence and Risk Factors in Patients Undergoing Hematopoietic Stem Cell Transplantation.Miranda Benfield, Jiaxian He, Justin Arnall, Whitney Kaizen, Elizabeth Jandrisevits
Transplantation and Cellular Therapy. 2025-02-01 - American Society of Hematology: building a comprehensive minority recruitment and retention professional program.Margo R Rollins, Rahma M Warsame, Melody Smith, Arturo Molina, Rayne H Rouce
Blood Advances. 2024-12-24 - Biologically Randomized Comparison of Haploidentical Versus Human Leukocyte Antigen-Matched Related Donor Reduced-Intensity Conditioning Hematopoietic Cell Transplanta...Michael R Grunwald, Wei Sha, Jiaxian He, Srinivasa Sanikommu, Jonathan M Gerber
Transplantation and Cellular Therapy. 2024-12-01
Abstracts/Posters
- Minorities Do Not Have Worse Outcomes for Diffuse Large B Cell Lymphoma (DLBCL) If Optimally ManagedBelinda R Avalos, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019
- Patient Reported Financial Toxicity in Myeloproliferative NeoplasmsBelinda R Avalos, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
- Alternative Splicing and Intronic Polyadenylation Post-Transcriptionally Regulate CSF3R Via a Cryptic ExonBelinda R Avalos, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019
- Join now to see all
Press Mentions
Sickle Cell Trait Widely Misinterpreted as Cause of DeathFebruary 12th, 2025- New Study Reveals No Connection Between Sickle Cell Trait and Risk of Sudden DeathJanuary 30th, 2025
- No Scientific Link Found Between Sickle Cell Trait and Sudden DeathJanuary 30th, 2025
- Join now to see all
Grant Support
- G-CSF Receptor And UbiquitinationNational Institute Of Diabetes And Digestive And Kidney Diseases2005–2006
- Loss Of Negative Signaling By The G-CSFR In AMLNational Cancer Institute2000–2002
- Loss Of Negative Signaling By The Gcsfr In AMLNational Cancer Institute1999
- G-CSFR Mutations--A Novel Mechanism Of LeukemogenesisNational Cancer Institute1997–1998
- Human Erythroid-Potentiating ActivityNational Heart, Lung, And Blood Institute1987–1990
- Human Erythroid-Potentiating ActivityNational Heart, Lung, And Blood Institute1986
Committees
- Member, American Society of Hematology Executive Committee 2015 - Present
- Chair, American Society of Hematology, Committee on Promoting Diversity 2014 - Present
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
